Cleared Traditional

K180770 - Propeller Sensor for Neohaler

K180770 is an FDA 510(k) clearance for Propeller Sensor for Neohaler, manufactured by Reciprocal Labs Corporation. The device is a Class 2 Anesthesiology device with product code CAF cleared through the Traditional 510(k) pathway after a 131-day FDA review.

K180770 · Reciprocal Labs Corporation · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2018
Decision
131d
Days
Class 2
Risk

K180770 is an FDA 510(k) clearance for the Propeller Sensor for Neohaler. Classified as Nebulizer (direct Patient Interface) (product code CAF), Class II - Special Controls.

Submitted by Reciprocal Labs Corporation (Madison, US). The FDA issued a Cleared decision on August 1, 2018 after a review of 131 days - within the typical 510(k) review window.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5630 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Reciprocal Labs Corporation devices

FDA 510(k) Submission Details - K180770

510(k) Number K180770 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 23, 2018
Decision Date August 01, 2018
Days to Decision 131 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
9d faster than avg
Panel avg: 140d · This submission: 131d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAF Device Classification - Class 2, Special Controls

Product Code CAF Nebulizer (direct Patient Interface)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAF Nebulizer (direct Patient Interface)

All 349
Devices cleared under the same product code (CAF) and FDA review panel - the closest regulatory comparables to K180770.
Hailie Sensor
K181405 · Adherium (Nz), Ltd. · Dec 2018
Portable Nebulizer
K180871 · Microbase Technology Corporation · Sep 2018
Intelligent Mesh Nebulizer
K171549 · Qingdao Future Medical Technology Co., Ltd. · Aug 2018
Smartinhaler
K180407 · Adherium (Nz), Ltd. · Jul 2018
HOMED Mesh Nebulizer
K170886 · Shenzhen Homed Medical Device Co., Ltd. · Jun 2018
MC 300R* Nebulizer
K173825 · Trudell Medical International · May 2018